TRACT Therapeutics, Inc
Biotechnology - Chicago, IL, United States
TRACT Therapeutics, Inc Employees
TRACT Therapeutics, Inc Senior Management
TRACT Therapeutics, Inc Details
TRACT Therapeutics, Inc. has developed a novel approach for restoring immune balance in patients receiving a solid organ transplant or in patients suffering from an autoimmune disease. This therapeutic approach may potentially reduce the chance of organ rejection following a transplant or transfer a patient suffering from an autoimmune disease into a state of remission.The proprietary technology is based on a platform which can be utilized to treat solid organ transplant patients, as well as a number of autoimmune disorders such as Crohn's Disease. For organ transplant, it shows great promise in preventing rejection of a donated organ, thereby, reducing the need for a second transplant. Over the next few years, TRACT's TregCel™ personalized therapy could transform the medical approach in transplant medicine by dramatically reducing or eliminating the lifelong use of toxic anti-rejection drugs.
TRACT Therapeutics, Inc Technologies
Email Providers
Gmail
Load Balancers
Nginx
Fonts
Google Font API
Other
Mobile Friendly
Analytics and Tracking
Gauges